Because of the time-sensitive nature of clinical trials, a good plan at the start can make the difference between an opportunity seized and an opportunity lost. The experience of Integrium allows us to suitably plan our clients’ trials to help maximize clinical and marketing success. Each of our departments works closely together and with our clients during this planning process. We first consult the literature to understand what has been done and what can be done, including the appropriate end points. Then, biostatisticians and clinicians collaborate to ensure that studies can be adequately powered and our clients’ objectives efficiently achieved. Project managers and clinical research associates proactively anticipate challenges and devise strategies to overcome them.

Only a company with this depth of cardiovascular and metabolic disease expertise can offer this service with such a high degree of confidence, efficiency and accuracy. What’s more, Integrium’s expertise also means we have a dependable network of investigator sites with an excellent record of patient enrollment, data quality, and cooperation. This gives us, and consequently our clients, an advantage when planning for and determining the feasibility of clinical trials and mitigating risks inherent in each program.